Cardiothoracic Surgical Trials Network (CTSN)
@CTSN16
Followers
719
Following
10
Media
4
Statuses
15
Twitter account of the NIH/NHLBI Cardiothoracic Surgical Trials Network (CTSN). Working together to improve cardiovascular disease outcomes
United States
Joined February 2019
With support from an @NIH @nih_nhlbi grant and in collaboration w/ @CTSN16 we are accepting applications for a national implementation science scholar in CT surgery. This innovative #clinicalresearch program can be completed during residency! More info at https://t.co/HEuRrzo6CF
1
38
52
A great honor to receive this @NIH @nih_nhlbi grant in cardiac surgery @CTSN16! Will increase access to clinical trials for rural patients and train new researchers. https://t.co/B4YGDvfn4y
@NHHeartAssoc @MaineMed @NPRHealth @nhpr @NH1dotcom @VNewsUV @nhmagazine @NHPRExchange
0
4
27
See my last tweet. Is TAVR v SAVR RCT in bicuspid AS mandatory, desirable or unnecessary? Is it feasible?
1
10
16
Gennaro Giustino, MD from Mount Sinai and CTSN presents research showing worse outcomes for women with severe IMR @CTSN16 , @iamritu
#ACC19 research shows women with severe ischemic #mitralregurgitation experience higher mortality and worse quality of life after mitral valve surgery compared with men. Read full study in #JACCHF: https://t.co/FLyLM9qmSB
@g_giustinoMD @JudyHungMD @coconnormd
2
10
23
#ACC19 research shows women with severe ischemic #mitralregurgitation experience higher mortality and worse quality of life after mitral valve surgery compared with men. Read full study in #JACCHF: https://t.co/FLyLM9qmSB
@g_giustinoMD @JudyHungMD @coconnormd
1
12
20
Congrats to @DartmouthHitch CT surgery and all other sites involved in this trial. @CTSN16
We are excited to announce that the CTSN has completed the enrollment of the VEST trial! Results will be available in 1 year. We would like to congratulate the investigators and the teams for the quick enrollment. We are thankful to the patients who participated in this study
0
1
9
The primary endpoint of the trial is the burden of intimal hyperplasia (area in mm2) as assessed by IVUS at 12 months after the procedure.
1
2
3
What is the VEST trial? This is a randomized within-subject trial evaluating the efficacy and safety of the VEST device applied to SVGs in pts with multivessel CAD undergoing CABG with IMA-LAD and 2 or more SVGs. Full trial details can be found here:
1
1
2
What is the VEST device? This is a cobalt-chromium external scaffold (Vascular Graft Solutions Ltd, Tel Aviv, Israel) designed to be applied to saphenous vein grafts (SVGs) during CABG surgery to improve long-term graft patency
1
2
2
We are excited to announce that the CTSN has completed the enrollment of the VEST trial! Results will be available in 1 year. We would like to congratulate the investigators and the teams for the quick enrollment. We are thankful to the patients who participated in this study
1
3
9
Thank you @DrIribarne !!
The @NIH @nih_nhlbi CT Surgical Trials Network @CTSN16
https://t.co/5hi6PLn2IK has a new twitter account. Pls follow and RT @JessicaLuc1 @ebender001 @tssmn #tssmn @STS_CTsurgery @AATSHQ @OuzounianMD @ArieBlitzMD @yaleHFdoc @drnikkistamp @TCTMD_Yael @ShelleyWood2 @HeartOTXHeartMD
0
0
1
My twitter survey on how results of the @NEJM ART trial https://t.co/PdCjg1cPj8 would change your practice with regard to use of BIMA in #CABG . A small sample size but what I was expecting @tssmn #TSSMN
0
3
3